Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Chidamide and PD-1 Inhibitor Plus Anlotinib for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed
ClinicalTrials.gov study NCT06547476. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell
ClinicalTrials.gov study NCT05049681. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06858969. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
ClinicalTrials.gov study NCT04086212. IPD Sharing: NO. Countries: 0. Publications: 0.
Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy
ClinicalTrials.gov study NCT07022301. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Posit
ClinicalTrials.gov study NCT05715840. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effects of Behavioral Interventions Based on Sensory Cues on FOG in PD After STN-DBS
ClinicalTrials.gov study NCT04147377. IPD Sharing: NO. Countries: 0. Publications: 0.
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
ClinicalTrials.gov study NCT03197571. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody
ClinicalTrials.gov study NCT04866485. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safinamide for Levodopa-induced Dyskinesia (PD-LID)
ClinicalTrials.gov study NCT03987750. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Probiotics Combined with Enteral Nutrition Reduces Postoperative Infectious Complications in PD
ClinicalTrials.gov study NCT06719596. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT04373083. IPD Sharing: YES. Countries: 0. Publications: 0.
A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-
ClinicalTrials.gov study NCT07108816. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL
ClinicalTrials.gov study NCT06573138. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours
ClinicalTrials.gov study NCT05537051. IPD Sharing: YES. Countries: 0. Publications: 0.
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
ClinicalTrials.gov study NCT05640726. IPD Sharing: NO. Countries: 0. Publications: 0.
Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels
ClinicalTrials.gov study NCT07360743. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT04634747. IPD Sharing: NO. Countries: 0. Publications: 0.
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects
ClinicalTrials.gov study NCT01695876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06418724. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.